메뉴 건너뛰기





Volumn 78, Issue 4, 2014, Pages 908-917

Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry

Author keywords

bleeding risk; novel oral anticoagulants; switching; VKA

Indexed keywords

ANTICOAGULANT AGENT; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; DABIGATRAN; MORPHOLINE DERIVATIVE; RIVAROXABAN; THIOPHENE DERIVATIVE; VITAMIN K GROUP;

EID: 84964314666     PISSN: None     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12391     Document Type: Article
Times cited : (52)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.